92 related articles for article (PubMed ID: 8697013)
1. Disease management program for asthma: baseline assessment of resource use.
MacKinnon NJ; Flagstad MS; Peterson CR; Mesch-Beatty K
Am J Health Syst Pharm; 1996 Mar; 53(5):535-41. PubMed ID: 8697013
[TBL] [Abstract][Full Text] [Related]
2. Drug utilization evaluation identifies costs associated with high use of beta-adrenergic agonists.
Stempel DA; Durcannin-Robbins JF; Hedblom EC; Woolf R; Sturm LL; Stempl AB
Ann Allergy Asthma Immunol; 1996 Feb; 76(2):153-8. PubMed ID: 8595534
[TBL] [Abstract][Full Text] [Related]
3. Factors affecting UK primary-care costs of managing patients with asthma over 5 years.
Dasgupta R; Guest JF
Pharmacoeconomics; 2003; 21(5):357-69. PubMed ID: 12627989
[TBL] [Abstract][Full Text] [Related]
4. Cross-sectional analysis of the relationship between national guideline recommended asthma drug therapy and emergency/hospital use within a managed care population.
Nestor A; Calhoun AC; Dickson M; Kalik CA
Ann Allergy Asthma Immunol; 1998 Oct; 81(4):327-30. PubMed ID: 9809496
[TBL] [Abstract][Full Text] [Related]
5. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.
Dormuth CR; Glynn RJ; Neumann P; Maclure M; Brookhart AM; Schneeweiss S
Clin Ther; 2006 Jun; 28(6):964-78; discussion 962-3. PubMed ID: 16860179
[TBL] [Abstract][Full Text] [Related]
6. Influence of an interventional program on resource use and cost in pediatric asthma.
Higgins JC; Kiser WR; McClenathan S; Tynan NL
Am J Manag Care; 1998 Oct; 4(10):1465-9. PubMed ID: 10338738
[TBL] [Abstract][Full Text] [Related]
7. Compliance with national asthma management guidelines and specialty care: a health maintenance organization experience.
Legorreta AP; Christian-Herman J; O'Connor RD; Hasan MM; Evans R; Leung KM
Arch Intern Med; 1998 Mar; 158(5):457-64. PubMed ID: 9508223
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Medicaid patients with asthma: comparison with treatment guidelines using disease-based drug utilization review methodology.
Laumann JM; Bjornson DC
Ann Pharmacother; 1998 Dec; 32(12):1290-4. PubMed ID: 9876808
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory therapy reduces total costs of asthma care compared with bronchodilation: the Asthma Outcomes Registry.
Huse DM; Russell MW; Weiss ST; Hartz SC
Am J Manag Care; 2000 Sep; 6(9):1045-50. PubMed ID: 11184066
[TBL] [Abstract][Full Text] [Related]
10. Health care utilization and cost among children with asthma who were enrolled in a health maintenance organization.
Lozano P; Fishman P; VonKorff M; Hecht J
Pediatrics; 1997 Jun; 99(6):757-64. PubMed ID: 9164766
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial of a pediatric asthma outreach program.
Greineder DK; Loane KC; Parks P
J Allergy Clin Immunol; 1999 Mar; 103(3 Pt 1):436-40. PubMed ID: 10069877
[TBL] [Abstract][Full Text] [Related]
12. Retrospective claims study of fluticasone propionate/salmeterol fixed-dose combination use as initial asthma controller therapy in children despite guideline recommendations.
Friedman HS; Eid NS; Crespi S; Wilcox TK; Reardon G
Clin Ther; 2009 May; 31(5):1056-63. PubMed ID: 19539106
[TBL] [Abstract][Full Text] [Related]
13. The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β
Pavord ID; Mathieson N; Scowcroft A; Pedersini R; Isherwood G; Price D
NPJ Prim Care Respir Med; 2017 Mar; 27(1):17. PubMed ID: 28270657
[TBL] [Abstract][Full Text] [Related]
14. Double trouble: impact of inappropriate use of asthma medication on the use of health care resources.
Anis AH; Lynd LD; Wang XH; King G; Spinelli JJ; Fitzgerald M; Bai T; Paré P
CMAJ; 2001 Mar; 164(5):625-31. PubMed ID: 11258208
[TBL] [Abstract][Full Text] [Related]
15. Effect of an emergency department asthma program on acute asthma care.
Emond SD; Woodruff PG; Lee EY; Singh AK; Camargo CA
Ann Emerg Med; 1999 Sep; 34(3):321-5. PubMed ID: 10459087
[TBL] [Abstract][Full Text] [Related]
16. Medicaid's beta 2-agonist recipients and their treatment by national standards.
Reddy P; Kelly ET; Kophazi ME; Geary EA; Markelon JD; Welter KJ
Ann Pharmacother; 2001 Jun; 35(6):682-6. PubMed ID: 11408984
[TBL] [Abstract][Full Text] [Related]
17. Intervention to reduce unnecessary dispensing of short-acting {beta}-agonists in patients with asthma.
Wong MD; Manley RT; Stettin G; Chen W; Salmun LM
Ann Pharmacother; 2010 Apr; 44(4):623-9. PubMed ID: 20233916
[TBL] [Abstract][Full Text] [Related]
18. Case management of asthma for family practice patients: a pilot study.
Dinelli DL; Higgins JC
Mil Med; 2002 Mar; 167(3):231-4. PubMed ID: 11901573
[TBL] [Abstract][Full Text] [Related]
19. Inhaled steroids and the risk of hospitalization for asthma.
Donahue JG; Weiss ST; Livingston JM; Goetsch MA; Greineder DK; Platt R
JAMA; 1997 Mar; 277(11):887-91. PubMed ID: 9062326
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of asthma management in the Fallon Community Health Plan from 1988 to 1991.
Lanes SF; Birmann BM; Walker AM; Sheffer AL; Rosiello RA; Lewis BE; Dreyer NA
Pharmacoeconomics; 1996 Oct; 10(4):378-85. PubMed ID: 10163579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
